메뉴 건너뛰기
Primary Care Respiratory Journal
Volumn 19, Issue 4, 2010, Pages 326-334
Co-morbidities of COPD in primary care: Frequency, relation to COPD, and treatment consequences
Author keywords

Asthma; Co morbidities; COPD; Diagnosis; Systemic inflammation
Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; MACROLIDE; METHYLDOPA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALBUTAMOL; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; WARFARIN;
EID: 79551639214     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2010.00053     Document Type: Review
Times cited : (60)
References (78)
  • 1
    • 18844376820 scopus 로고    scopus 로고
    • Global Initiative for Chronic Obstructive Lung Disease, Bethesda: National Heart, Lung and Blood Institute, Available at, Date accessed 24 November 2009(updated 2008)
    • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2008). Bethesda: National Heart, Lung and Blood Institute, 2008. Available at http://www.goldcopd.org. Date accessed 24 November 2009.
    • (2008) Global Strategy For the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease
  • 2
    • 60249084587 scopus 로고    scopus 로고
    • Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: The Rotterdam study
    • van Durme YM, Verhamme KM, Stijnen T, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 2009;135(2):368-377. http://dx.doi.org/10.1378/chest.08-0684.
    • (2009) Chest , vol.135 , Issue.2 , pp. 368-377
    • van Durme, Y.M.1    Verhamme, K.M.2    Stijnen, T.3
  • 3
    • 45349099767 scopus 로고    scopus 로고
    • Primary care of the patient with chronic obstructive pulmonary disease-part 1: Frontline prevention and early diagnosis
    • Radin A, Cote C. Primary care of the patient with chronic obstructive pulmonary disease-part 1: frontline prevention and early diagnosis. Am J Med 2008;121(7 Suppl):S3-S12. http://dx.doi.org/10.1016/j.amjmed.2008.04.002.
    • (2008) Am J Med , vol.121 , Issue.7 SUPPL
    • Radin, A.1    Cote, C.2
  • 4
    • 47949126693 scopus 로고    scopus 로고
    • Correlation between high-resolution computed tomography features and patients' characteristics in chronic obstructive pulmonary disease
    • Gupta PP, Yadav R, Verma M, et al. Correlation between high-resolution computed tomography features and patients' characteristics in chronic obstructive pulmonary disease. Ann Thorac Med 2008;3(3):87-93. http://dx.doi.org/10.4103/1817-1737.39676.
    • (2008) Ann Thorac Med , vol.3 , Issue.3 , pp. 87-93
    • Gupta, P.P.1    Yadav, R.2    Verma, M.3
  • 5
    • 1842552109 scopus 로고    scopus 로고
    • Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper
    • Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946. http://dx.doi.org/10.1183/09031936.04.00014304.
    • (2004) Eur Respir J , vol.23 , Issue.6 , pp. 932-946
    • Celli, B.R.1    Macnee, W.2
  • 6
    • 34447335302 scopus 로고    scopus 로고
    • Role of primary care in early diagnosis and effective management of COPD
    • Bellamy D, Smith J. Role of primary care in early diagnosis and effective management of COPD. Int J Clin Pract 2007;61(8):1380-1389. http://dx.doi.org/10.1111/j.1742-1241.2007.01447.x.
    • (2007) Int J Clin Pract , vol.61 , Issue.8 , pp. 1380-1389
    • Bellamy, D.1    Smith, J.2
  • 7
    • 41149103891 scopus 로고    scopus 로고
    • Under-diagnosis of chronic obstructive pulmonary disease: A qualitative study in primary care
    • Walters JA, Hansen EC, Walters EH, Wood-Baker R. Under-diagnosis of chronic obstructive pulmonary disease: a qualitative study in primary care. Respir Med 2008;102(5):738-743. http://dx.doi.org/10.1016/j.rmed.2007.12.008.
    • (2008) Respir Med , vol.102 , Issue.5 , pp. 738-743
    • Walters, J.A.1    Hansen, E.C.2    Walters, E.H.3    Wood-Baker, R.4
  • 8
    • 70349694402 scopus 로고    scopus 로고
    • Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk
    • Guerra S, Sherrill DL, Venker C, et al. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009;64(10):894-900. http://dx.doi.org/10.1136/thx.2008.110619
    • (2009) Thorax , vol.64 , Issue.10 , pp. 894-900
    • Guerra, S.1    Sherrill, D.L.2    Venker, C.3
  • 9
    • 31144464118 scopus 로고    scopus 로고
    • Co-morbidity in older patients with COPD--its impact on health service utilisation and quality of life, a community study
    • Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD--its impact on health service utilisation and quality of life, a community study. Age Ageing 2006;35(1):33-37. http://dx.doi.org/10.1093/ageing/afj002.
    • (2006) Age Ageing , vol.35 , Issue.1 , pp. 33-37
    • Yeo, J.1    Karimova, G.2    Bansal, S.3
  • 10
    • 73449086493 scopus 로고    scopus 로고
    • Global Initiative for Asthma, Bethesda, MD: National Heart, Lung and Blood Institute, 2009. Available at, Date accessed 24 November
    • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Heart, Lung and Blood Institute, 2009. Available at http:/www.ginasthma.com/GuidelinesResources.asp. Date accessed 24 November 2009.
    • (2009) Global Strategy For Asthma Management and Prevention
  • 11
    • 0033994635 scopus 로고    scopus 로고
    • Mechanisms in COPD: Differences from asthma
    • Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 2000;117(2 Suppl):10S-14S. http://dx.doi.org/10.1378/chest.117.2_suppl.10S.
    • (2000) Chest , vol.117 , Issue.2 SUPPL
    • Barnes, P.J.1
  • 12
    • 35148893108 scopus 로고    scopus 로고
    • Systemic effects of chronic obstructive pulmonary disease: What we know and what we don't know (but should)
    • Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc 2007;4(7):522-525. http://dx.doi.org/10.1513/pats.200701-004FM.
    • (2007) Proc Am Thorac Soc , vol.4 , Issue.7 , pp. 522-525
    • Agusti, A.1
  • 13
    • 66749141807 scopus 로고    scopus 로고
    • Systemic manifestations and comorbidities of COPD
    • Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33(5):1165-1185. http://dx.doi.org/10.1183/09031936.00128008.
    • (2009) Eur Respir J , vol.33 , Issue.5 , pp. 1165-1185
    • Barnes, P.J.1    Celli, B.R.2
  • 14
    • 27144525197 scopus 로고    scopus 로고
    • Patterns of comorbidities in newly diagnosed COPD and asthma in primary care
    • Soriano JB, Visick GT, Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128(4):2099-2107. http://dx.doi.org/10.1378/chest.128.4.2099.
    • (2005) Chest , vol.128 , Issue.4 , pp. 2099-2107
    • Soriano, J.B.1    Visick, G.T.2    Muellerova, H.3
  • 15
    • 69749096425 scopus 로고    scopus 로고
    • Integrated disease management improves one-year quality of life in primary care COPD patients: A controlled clinical trial
    • Chavannes NH, Grijsen M, van den Akker M, et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Resp J 2009;18(3):171-176. http://dx.doi.org/10.3132/pcrj.2009.00003.
    • (2009) Prim Care Resp J , vol.18 , Issue.3 , pp. 171-176
    • Chavannes, N.H.1    Grijsen, M.2    van den Akker, M.3
  • 16
    • 64749104557 scopus 로고    scopus 로고
    • Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects
    • Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009;135(4):975-982. http://dx.doi.org/10.1378/chest.08-2062.
    • (2009) Chest , vol.135 , Issue.4 , pp. 975-982
    • Burgel, P.R.1    Nesme-Meyer, P.2    Chanez, P.3
  • 17
    • 33846248798 scopus 로고    scopus 로고
    • Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm
    • de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175(1):32-39. http://dx.doi.org/10.1164/rccm.200603-381OC.
    • (2007) Am J Respir Crit Care Med , vol.175 , Issue.1 , pp. 32-39
    • de Marco, R.1    Accordini, S.2    Cerveri, I.3
  • 18
    • 33845361633 scopus 로고    scopus 로고
    • Mortality in COPD: Role of comorbidities
    • Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28(6):1245-1257. http://dx.doi.org/10.1183/09031936.00133805.
    • (2006) Eur Respir J , vol.28 , Issue.6 , pp. 1245-1257
    • Sin, D.D.1    Anthonisen, N.R.2    Soriano, J.B.3    Agusti, A.G.4
  • 19
    • 27144461153 scopus 로고    scopus 로고
    • COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program
    • Sidney S, Sorel M, Quesenberry CP, Jr., et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128(4):2068-2075. http://dx.doi.org/10.1378/chest.128.4.2068.
    • (2005) Chest , vol.128 , Issue.4 , pp. 2068-2075
    • Sidney, S.1    Sorel, M.2    Quesenberry Jr, C.P.3
  • 20
    • 0037465734 scopus 로고    scopus 로고
    • Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
    • Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107(11):1514-1519. http://dx.doi.org/10.1161/01.CIR.0000056767.69054.B3.
    • (2003) Circulation , vol.107 , Issue.11 , pp. 1514-1519
    • Sin, D.D.1    Man, S.F.2
  • 21
    • 0030976501 scopus 로고    scopus 로고
    • Corticosteroid reversibility in COPD is related to features of asthma
    • Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997;155(5):1529-1534.
    • (1997) Am J Respir Crit Care Med , vol.155 , Issue.5 , pp. 1529-1534
    • Chanez, P.1    Vignola, A.M.2    O'Shaugnessy, T.3
  • 22
    • 36549028855 scopus 로고    scopus 로고
    • Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease
    • Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008;14(1):31-38. http://dx.doi.org/10.1097/MCP.0b013e3282f19846.
    • (2008) Curr Opin Pulm Med , vol.14 , Issue.1 , pp. 31-38
    • Mauad, T.1    Dolhnikoff, M.2
  • 23
    • 57149085345 scopus 로고    scopus 로고
    • Co-morbidities in people with COPD: A result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?
    • Yawn BP, Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation? Prim Care Resp J 2008;17(4):199-205. http://dx.doi.org/10.3132/pcrj.2008.00021.
    • (2008) Prim Care Resp J , vol.17 , Issue.4 , pp. 199-205
    • Yawn, B.P.1    Kaplan, A.2
  • 24
    • 79551616769 scopus 로고    scopus 로고
    • Patients in primary care using inhaled medication; diagnosis, disease severity and disease control. Presented at the International Primary Care Respiratory Group meeting Seville
    • May
    • van Heijst ECM, Riemersma RA, Meijer RJ, van der Molen T. Patients in primary care using inhaled medication; diagnosis, disease severity and disease control. Presented at the International Primary Care Respiratory Group meeting Seville, Spain; 28-31 May 2008.
    • (2008) Spain , pp. 28-31
    • van Heijst, E.C.M.1    Riemersma, R.A.2    Meijer, R.J.3    van der Molen, T.4
  • 25
    • 59249105541 scopus 로고    scopus 로고
    • Differential assessment and management of asthma vs chronic obstructive pulmonary disease
    • Yawn BP. Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medscape J Med 2009;11(1):20.
    • (2009) Medscape J Med , vol.11 , Issue.1 , pp. 20
    • Yawn, B.P.1
  • 26
    • 62549124564 scopus 로고    scopus 로고
    • Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: The DIDASCO2 study
    • Buffels J, Degryse J, Liistro G. Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study. Prim Care Resp J 2009;18(1):34-40. http://dx.doi.org/10.3132/pcrj.2008.00047.
    • (2009) Prim Care Resp J , vol.18 , Issue.1 , pp. 34-40
    • Buffels, J.1    Degryse, J.2    Liistro, G.3
  • 27
    • 0002770296 scopus 로고
    • The host factor in bronchitis
    • Orie N, Sluiter HJ, eds., Assen, the Netherlands: Royal van Gorcum
    • Orie NMG, Sluiter HJ, de Vries K, et al. The host factor in bronchitis. In: Orie N, Sluiter HJ, eds. Bronchitis. Assen, the Netherlands: Royal van Gorcum, 1961. p.43-59.
    • (1961) Bronchitis , pp. 43-59
    • Orie, N.M.G.1    Sluiter, H.J.2    de Vries, K.3
  • 29
    • 32944475098 scopus 로고    scopus 로고
    • Genetics and the Dutch Hypothesis
    • Ruse CE, Parker SG. Genetics and the Dutch Hypothesis. Chron Respir Dis 2004;1(2):105-113.
    • (2004) Chron Respir Dis , vol.1 , Issue.2 , pp. 105-113
    • Ruse, C.E.1    Parker, S.G.2
  • 30
    • 0032558685 scopus 로고    scopus 로고
    • A 15-year follow-up study of ventilatory function in adults with asthma
    • Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339(17):1194-1200.
    • (1998) N Engl J Med , vol.339 , Issue.17 , pp. 1194-1200
    • Lange, P.1    Parner, J.2    Vestbo, J.3
  • 31
    • 3242719685 scopus 로고    scopus 로고
    • Asthma as a risk factor for COPD in a longitudinal study
    • Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126(1):59-65. http://dx.doi.org/10.1378/chest.126.1.59.
    • (2004) Chest , vol.126 , Issue.1 , pp. 59-65
    • Silva, G.E.1    Sherrill, D.L.2    Guerra, S.3    Barbee, R.A.4
  • 32
    • 0345701349 scopus 로고    scopus 로고
    • Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up
    • Vonk JM, Jongepier H, Panhuysen CI, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58(4):322-327. http://dx.doi.org/10.1136/thorax.58.4.322.
    • (2003) Thorax , vol.58 , Issue.4 , pp. 322-327
    • Vonk, J.M.1    Jongepier, H.2    Panhuysen, C.I.3
  • 33
    • 33846012192 scopus 로고    scopus 로고
    • Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure
    • Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007;49(2):171-180. http://dx.doi.org/10.1016/j.jacc.2006.08.046.
    • (2007) J Am Coll Cardiol , vol.49 , Issue.2 , pp. 171-180
    • Le Jemtel, T.H.1    Padeletti, M.2    Jelic, S.3
  • 34
    • 33845371731 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease severity and cardiovascular outcomes
    • Curkendall SM, Lanes S, de Luise C, et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol 2006;21(11):803-813. http://dx.doi.org/10.1007/s10654-006-9066-1.
    • (2006) Eur J Epidemiol , vol.21 , Issue.11 , pp. 803-813
    • Curkendall, S.M.1    Lanes, S.2    de Luise, C.3
  • 35
    • 33644679150 scopus 로고    scopus 로고
    • Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: Cross sectional diagnostic study
    • Rutten FH, Moons KG, Cramer MJ, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005;331(7529):1379. http://dx.doi.org/10.1136/bmj.38664.661181.55.
    • (2005) BMJ , vol.331 , Issue.7529 , pp. 1379
    • Rutten, F.H.1    Moons, K.G.2    Cramer, M.J.3
  • 36
    • 33847020010 scopus 로고    scopus 로고
    • Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes
    • Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 2007;99(5):636-641. http://dx.doi.org/10.1016/j.amjcard.2006.09.112.
    • (2007) Am J Cardiol , vol.99 , Issue.5 , pp. 636-641
    • Salisbury, A.C.1    Reid, K.J.2    Spertus, J.A.3
  • 37
    • 0038056173 scopus 로고    scopus 로고
    • Pulmonary hypertension in chronic obstructive pulmonary disease
    • Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003;21(5):892-905. http://dx.doi.org/10.1183/09031936.03.00115402.
    • (2003) Eur Respir J , vol.21 , Issue.5 , pp. 892-905
    • Barbera, J.A.1    Peinado, V.I.2    Santos, S.3
  • 38
    • 54249131732 scopus 로고    scopus 로고
    • Pulmonary vascular involvement in COPD
    • Peinado VI, Pizarro S, Barbera JA. Pulmonary vascular involvement in COPD. Chest 2008;134(4):808-814. http://dx.doi.org/10.1378/chest.08-0820.
    • (2008) Chest , vol.134 , Issue.4 , pp. 808-814
    • Peinado, V.I.1    Pizarro, S.2    Barbera, J.A.3
  • 39
    • 0035143243 scopus 로고    scopus 로고
    • Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function
    • Engstrom G, Hedblad B, Valind S, Janzon L. Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function. J Hypertens 2001;19(2):295-301.
    • (2001) J Hypertens , vol.19 , Issue.2 , pp. 295-301
    • Engstrom, G.1    Hedblad, B.2    Valind, S.3    Janzon, L.4
  • 40
    • 33845915111 scopus 로고    scopus 로고
    • Lung function and ischemic stroke incidence: The Atherosclerosis Risk in Communities study
    • Hozawa A, Billings JL, Shahar E, et al. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest 2006;130(6):1642-1649. http://dx.doi.org/10.1378/chest.130.6.1642
    • (2006) Chest , vol.130 , Issue.6 , pp. 1642-1649
    • Hozawa, A.1    Billings, J.L.2    Shahar, E.3
  • 41
    • 55249090655 scopus 로고    scopus 로고
    • Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs
    • Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008;134(4 Suppl):43S-56S. http://dx.doi.org/10.1378/chest.08-0342.
    • (2008) Chest , vol.134 , Issue.4 SUPPL
    • Maurer, J.1    Rebbapragada, V.2    Borson, S.3
  • 42
    • 31344445894 scopus 로고    scopus 로고
    • A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease
    • Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31(1):58-69. http://dx.doi.org/10.1016/j.jpainsymman.2005.06.007.
    • (2006) J Pain Symptom Manage , vol.31 , Issue.1 , pp. 58-69
    • Solano, J.P.1    Gomes, B.2    Higginson, I.J.3
  • 43
    • 34548277025 scopus 로고    scopus 로고
    • From COPD to chronic systemic inflammatory syndrome?
    • Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797-799. http://dx.doi.org/10.1016/S0140-6736(07)61383-X.
    • (2007) Lancet , vol.370 , Issue.9589 , pp. 797-799
    • Fabbri, L.M.1    Rabe, K.F.2
  • 44
    • 62149136593 scopus 로고    scopus 로고
    • Depressive symptoms as predictors of mortality in patients with COPD
    • de Voogd JN, Wempe JB, Koeter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009;135(3):619-625. http://dx.doi.org/10.1378/chest.08-0078.
    • (2009) Chest , vol.135 , Issue.3 , pp. 619-625
    • de Voogd, J.N.1    Wempe, J.B.2    Koeter, G.H.3
  • 45
    • 0027482124 scopus 로고
    • Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease
    • Argyropoulou P, Patakas D, Koukou A, et al. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 1993;60(4):216-220. http://dx.doi.org/10.1159/000196202
    • (1993) Respiration , vol.60 , Issue.4 , pp. 216-220
    • Argyropoulou, P.1    Patakas, D.2    Koukou, A.3
  • 46
    • 0035004118 scopus 로고    scopus 로고
    • One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease
    • Kunik ME, Braun U, Stanley MA, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001;31(4):717-723. http://dx.doi.org/10.1017/S0033291701003890.
    • (2001) Psychol Med , vol.31 , Issue.4 , pp. 717-723
    • Kunik, M.E.1    Braun, U.2    Stanley, M.A.3
  • 47
    • 33645983653 scopus 로고    scopus 로고
    • Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD
    • Guell R, Resqueti V, Sangenis M, et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 2006;129(4):899-904. http://dx.doi.org/10.1378/chest.129.4.899.
    • (2006) Chest , vol.129 , Issue.4 , pp. 899-904
    • Guell, R.1    Resqueti, V.2    Sangenis, M.3
  • 48
    • 67650752158 scopus 로고    scopus 로고
    • Mortality, Health Outcomes, and BodyMass Index in the Overweight Range
    • A Science Advisory From the American Heart Association
    • Lewis CE, McTigue KM, Burke LE, et al. Mortality, Health Outcomes, and BodyMass Index in the Overweight Range. A Science Advisory From the American Heart Association. Circulation 2009;119(25):3263-3271. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192574.
    • (2009) Circulation , vol.119 , Issue.25 , pp. 3263-3271
    • Lewis, C.E.1    McTigue, K.M.2    Burke, L.E.3
  • 49
    • 0028143215 scopus 로고
    • Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD
    • Engelen MP, Schols AM, Baken WC, et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994;7(10):1793-1797. http://dx.doi.org/10.1183/09031936.94.07101793.
    • (1994) Eur Respir J , vol.7 , Issue.10 , pp. 1793-1797
    • Engelen, M.P.1    Schols, A.M.2    Baken, W.C.3
  • 51
    • 0036264584 scopus 로고    scopus 로고
    • Systemic effects in COPD
    • Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121(5 Suppl):127S-130S. http://dx.doi.org/10.1378/chest.121.5_suppl.127S.
    • (2002) Chest , vol.121 , Issue.5 SUPPL
    • Wouters, E.F.1    Creutzberg, E.C.2    Schols, A.M.3
  • 52
    • 4644344756 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women
    • Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004;27(10):2478-2484. http://dx.doi.org/10.2337/diacare.27.10.2478.
    • (2004) Diabetes Care , vol.27 , Issue.10 , pp. 2478-2484
    • Rana, J.S.1    Mittleman, M.A.2    Sheikh, J.3
  • 53
    • 56249083570 scopus 로고    scopus 로고
    • Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
    • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32(4):962-969. http://dx.doi.org/10.1183/09031936.00012408.
    • (2008) Eur Respir J , vol.32 , Issue.4 , pp. 962-969
    • Mannino, D.M.1    Thorn, D.2    Swensen, A.3    Holguin, F.4
  • 54
    • 0032587240 scopus 로고    scopus 로고
    • The role of TNFalpha and TNF receptors in obesity and insulin resistance
    • Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999;245(6):621-625. http://dx.doi.org/10.1046/j.1365-2796.1999.00490.x.
    • (1999) J Intern Med , vol.245 , Issue.6 , pp. 621-625
    • Hotamisligil, G.S.1
  • 55
    • 33846215065 scopus 로고    scopus 로고
    • Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers
    • Purdue MP, Gold L, Jarvholm B, et al. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007;62(1):51-56. http://dx.doi.org/10.1136/thx.2006.064196.
    • (2007) Thorax , vol.62 , Issue.1 , pp. 51-56
    • Purdue, M.P.1    Gold, L.2    Jarvholm, B.3
  • 56
    • 22044431902 scopus 로고    scopus 로고
    • Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: A systematic review and meta-analysis
    • Wasswa-Kintu S, Gan WQ, Man SF, et al. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005;60(7):570-575. http://dx.doi.org/10.1136/thx.2004.037135.
    • (2005) Thorax , vol.60 , Issue.7 , pp. 570-575
    • Wasswa-Kintu, S.1    Gan, W.Q.2    Man, S.F.3
  • 57
    • 34547588840 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers
    • Turner MC, Chen Y, Krewski D, et al. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007;176(3):285-290. http://dx.doi.org/10.1164/rccm.200612-1792OC.
    • (2007) Am J Respir Crit Care Med , vol.176 , Issue.3 , pp. 285-290
    • Turner, M.C.1    Chen, Y.2    Krewski, D.3
  • 58
    • 0036173978 scopus 로고    scopus 로고
    • COPD and osteoporosis
    • Biskobing DM. COPD and osteoporosis. Chest 2002;121(2):609-620. http://dx.doi.org/10.1378/chest.121.2.609.
    • (2002) Chest , vol.121 , Issue.2 , pp. 609-620
    • Biskobing, D.M.1
  • 59
    • 40049092924 scopus 로고    scopus 로고
    • Osteoporosis in chronic obstructive pulmonary disease patients
    • Jorgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2008;14(2):122-127. http://dx.doi.org/10.1097/MCP.0b013e3282f4efb6.
    • (2008) Curr Opin Pulm Med , vol.14 , Issue.2 , pp. 122-127
    • Jorgensen, N.R.1    Schwarz, P.2
  • 60
    • 3242728658 scopus 로고    scopus 로고
    • A meta-analysis of previous fracture and subsequent fracture risk
    • Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004;35(2):375-382. http://dx.doi.org/10.1016/j.bone.2004.03.024.
    • (2004) Bone , vol.35 , Issue.2 , pp. 375-382
    • Kanis, J.A.1    Johnell, O.2    de Laet, C.3
  • 61
    • 79551616395 scopus 로고    scopus 로고
    • British National Formulary
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain, London: BMJ, 2010. Available at, Date accessed 23 April
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 59. Methyldopa. London: BMJ, 2010. Available at http://bnf.org/bnf/bnf/current/41001i611.htm. Date accessed 23 April 2010.
    • (2010) Methyldopa , pp. 59
  • 62
    • 79551616395 scopus 로고    scopus 로고
    • British National Formulary
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain, London: BMJ, Available at, Date accessed 23 April 2010
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 59. Corticosteroids. London: BMJ, 2010. Available at http://bnf.org/bnf/bnf/current/41001i484.htm. Date accessed 23 April 2010.
    • (2010) Corticosteroids , pp. 59
  • 63
    • 79551616395 scopus 로고    scopus 로고
    • British National Formulary
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain, London: BMJ, Available at, Date accessed 23 April 2010
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 59. Selective beta2 agonists. London: BMJ, 2010. Available at http://bnf.org/bnf/bnf/current/2878.htm. Date accessed 23 April 2010.
    • (2010) Selective Beta2 Agonists , pp. 59
  • 64
    • 0026571668 scopus 로고
    • Effect of salbutamol on digoxin pharmacokinetics
    • Edner M, Jogestrand T, Dahlqvist R. Effect of salbutamol on digoxin pharmacokinetics. Eur J Clin Pharmacol 1992;42(2):197-201.
    • (1992) Eur J Clin Pharmacol , vol.42 , Issue.2 , pp. 197-201
    • Edner, M.1    Jogestrand, T.2    Dahlqvist, R.3
  • 65
    • 43449117521 scopus 로고    scopus 로고
    • Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease
    • Falk JA, Minai OA, Mosenifar Z. Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5(4):506-512. http://dx.doi.org/10.1513/pats.200707-096ET.
    • (2008) Proc Am Thorac Soc , vol.5 , Issue.4 , pp. 506-512
    • Falk, J.A.1    Minai, O.A.2    Mosenifar, Z.3
  • 66
    • 79551654046 scopus 로고    scopus 로고
    • GlaxoSmithKline, Advair Diskus/Advair Package Insert. Mississauga: GlaxoSmithKline Inc, Available at, Date accessed 23 April 2010
    • GlaxoSmithKline. Advair Diskus/Advair Package Insert. Mississauga: GlaxoSmithKline Inc., 2008. Available at http://www.gsk.ca/english/docspdf/Advair-Advair_Diskus_PM_20080808_EN.pdf. Date accessed 23 April 2010.
    • (2008)
  • 67
    • 33845635241 scopus 로고    scopus 로고
    • Effect of oral corticosteroids on chronic warfarin therapy
    • Hazlewood KA, Fugate SE, Harrison DL. Effect of oral corticosteroids on chronic warfarin therapy. Ann Pharmacother 2006;40(12):2101-2106. http://dx.doi.org/10.1345/aph.1H418
    • (2006) Ann Pharmacother , vol.40 , Issue.12 , pp. 2101-2106
    • Hazlewood, K.A.1    Fugate, S.E.2    Harrison, D.L.3
  • 68
    • 0035370434 scopus 로고    scopus 로고
    • Steroids and risk of upper gastrointestinal complications
    • Hernandez-Diaz S, Rodriguez LA. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol 2001;153(11):1089-1093.
    • (2001) Am J Epidemiol , vol.153 , Issue.11 , pp. 1089-1093
    • Hernandez-Diaz, S.1    Rodriguez, L.A.2
  • 69
    • 17844399598 scopus 로고    scopus 로고
    • Respiratory medications and the risk of cardiac arrhythmias
    • Huerta C, Lanes SF, Garcia Rodriguez LA. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 2005;16(3):360-366.
    • (2005) Epidemiology , vol.16 , Issue.3 , pp. 360-366
    • Huerta, C.1    Lanes, S.F.2    Garcia Rodriguez, L.A.3
  • 70
    • 0020697606 scopus 로고
    • Theophylline toxicity--a consequence of congestive heart failure
    • LeGatt DF. Theophylline toxicity--a consequence of congestive heart failure. Drug Intell Clin Pharm 1983;17(1):59-60.
    • (1983) Drug Intell Clin Pharm , vol.17 , Issue.1 , pp. 59-60
    • Legatt, D.F.1
  • 71
    • 0034523286 scopus 로고    scopus 로고
    • Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks
    • McEvoy CE, Niewoehner DE. Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks. Clin Chest Med 2000;21(4):739-752.
    • (2000) Clin Chest Med , vol.21 , Issue.4 , pp. 739-752
    • McEvoy, C.E.1    Niewoehner, D.E.2
  • 72
    • 70350121951 scopus 로고    scopus 로고
    • Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting betaagonists monotherapy for stable COPD: A systematic review
    • Rodrigo GJ, Castro-Rodriguez JA, Plaza V. Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting betaagonists monotherapy for stable COPD: a systematic review. Chest 2009;136(4):1029-1038. http://dx.doi.org/10.1378/chest.09-0821.
    • (2009) Chest , vol.136 , Issue.4 , pp. 1029-1038
    • Rodrigo, G.J.1    Castro-Rodriguez, J.A.2    Plaza, V.3
  • 73
    • 45849103106 scopus 로고    scopus 로고
    • Proarrhythmic potential of antimicrobial agents
    • Simko J, Csilek A, Karaszi J, Lorincz I. Proarrhythmic potential of antimicrobial agents. Infection 2008;36(3):194-206. http://dx.doi.org/10.1007/s15010-007-7211-8.
    • (2008) Infection , vol.36 , Issue.3 , pp. 194-206
    • Simko, J.1    Csilek, A.2    Karaszi, J.3    Lorincz, I.4
  • 74
    • 52449106502 scopus 로고    scopus 로고
    • Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
    • Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300(12):1439-1450. http://dx.doi.org/10.1001/jama.300.12.1439.
    • (2008) JAMA , vol.300 , Issue.12 , pp. 1439-1450
    • Singh, S.1    Loke, Y.K.2    Furberg, C.D.3
  • 75
    • 4344661580 scopus 로고    scopus 로고
    • A benefit-risk assessment of inhaled longacting beta2-agonists in the management of obstructive pulmonary disease
    • Sovani MP, Whale CI, Tattersfield AE. A benefit-risk assessment of inhaled longacting beta2-agonists in the management of obstructive pulmonary disease. Drug Saf 2004;27(10):689-715.
    • (2004) Drug Saf , vol.27 , Issue.10 , pp. 689-715
    • Sovani, M.P.1    Whale, C.I.2    Tattersfield, A.E.3
  • 77
    • 52749097999 scopus 로고    scopus 로고
    • Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis
    • van Gestel YR, Hoeks SE, Sin DD, et al. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008;178(7):695-700. http://dx.doi.org/10.1164/rccm.200803-384OC.
    • (2008) Am J Respir Crit Care Med , vol.178 , Issue.7 , pp. 695-700
    • van Gestel, Y.R.1    Hoeks, S.E.2    Sin, D.D.3
  • 78
    • 54949148789 scopus 로고    scopus 로고
    • Personality influences the reporting of side effects of inhaled corticosteroids in asthma patients
    • Foster JM, Sanderman R, van der Molen T, et al. Personality influences the reporting of side effects of inhaled corticosteroids in asthma patients. J Asthma 2008;45(8):664-669. http://dx.doi.org/10.1080/02770900802127022.
    • (2008) J Asthma , vol.45 , Issue.8 , pp. 664-669
    • Foster, J.M.1    Sanderman, R.2    van der Molen, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.